Table 1.

Correlation between TGM2 expression and clinicopathological features in patients with papillary thyroid cancer (n = 92).

Characteristic	n	TGM2		P value
		+	−
Age
<55	69	59 (85.5%)	10 (14.5%)	0.204
≥55	23	17 (73.9%)	6 (26.1%)
Gender
male	36	31 (86.1%)	5 (13.9%)	0.477
female	56	45 (80.4%)	11 (19.6%)
Tumor size
<2cm	65	53 (81.5%)	12 (18.5%)	0.674
≥2cm	27	23 (85.2%)	4 (14.8%)
Extrathyroidal invasion
yes	45	41 (91.1%)	4 (8.9%)	0.035*
no	47	35 (74.5%)	12 (25.5%)
Lymph node metastasis
yes	59	54 (91.5%)	5 (8.5%)	0.003*
no	33	22 (66.7%)	11 (33.3%)
Multicentricity
Yes	49	39 (79.6%)	10 (20.4%)	0.415
No	43	37 (86.0%)	6 (14.0%)
TNM stage
I–II	58	45 (77.6%)	13 (22.4%)	0.097
III–IV	34	31 (91.2%)	3 (8.8%)

*p < 0.05.